My AccountLog in

1 option

Which Markets (Don't) Drive Pharmaceutical Innovation? Evidence From U.S. Medicaid Expansions / Craig Garthwaite, Rebecca Sachs, Ariel Dora Stern.

NBER Working papersAvailable online

View online
Format:
Book
Author/Creator:
Garthwaite, Craig.
Contributor:
Sachs, Rebecca.
Stern, Ariel Dora.
National Bureau of Economic Research.
Series:
Working Paper Series (National Bureau of Economic Research) no. w28755.
NBER working paper series no. w28755
Language:
English
Physical Description:
1 online resource: illustrations (black and white);
Other Title:
Which Markets
Place of Publication:
Cambridge, Mass. National Bureau of Economic Research 2021.
Summary:
Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short-term and stronger incentives to develop products for the future. Prior research has documented a causal relationship between market size and pharmaceutical research and development (R&D) activities. The existing literature, however, provides no evidence of how this relationship varies across markets. We investigate whether recent expansions in state Medicaid programs caused an increase in R&D. We find no evidence of a response, potentially a result of Medicaid's low reimbursement for pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy.
Notes:
May 2021.
Print version record

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

HomeRelease notes

My Account

ShelfRequest an itemBookmarksFines and feesSettings

Guides

Using the Find catalogUsing Articles+Using your account